Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10023570
APP PUB NO 20170096425A1
SERIAL NO

15211702

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are compounds of the General Formula I:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ARRAY BIOPHARMA INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andrews, Steven W Boulder, US 121 3409
Blake, James F Boulder, US 124 1435
Chicarelli, Mark J Boulder, US 10 104
Golos, Adam Boulder, US 7 97
Haas, Julia Boulder, US 83 2074
Jiang, Yutong Boulder, US 86 2396
Kolakowski, Gabrielle R Boulder, US 73 976

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 17, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 17, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00